Market Cap ₹185 Cr.
Stock P/E -19.0
P/B 1.6
Current Price ₹398.8
Book Value ₹ 255.5
Face Value 10
52W High ₹550
Dividend Yield 0%
52W Low ₹ 360.4
JK Agri Genetics Ltd is an primarily India-based seed business enterprise. The Company is engaged in developing of non-perennial crops, inclusive of seeds. The Company affords agri and allied merchandise. The Company is in R&D, manufacturing, processing and advertising of cotton, maize, paddy, pearl millet, sorghum, sunflower, castor, mustard, wheat, sorghum sudan grass, fodder beet, tomato, okra, chillies and different vegetable seeds. The Company's merchandise include field crops, veggies, fodder plants and plant growth solutions. Its plant growth solution includes Nutrestar. The Company has production facilities to produce high-yielding hybrid seeds at various locations in Andhra Pradesh, Telangana and other states. The Company additionally has biotechnology research and development centre and seed processing plant at Hyderabad in Telangana and another seed processing plant at Kota in Rajasthan.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 5 | 41 | 69 | 116 | 16 | 23 | 46 | 80 | 9 | 23 |
| Other Income | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Income | 5 | 41 | 70 | 117 | 16 | 23 | 47 | 81 | 10 | 24 |
| Total Expenditure | 24 | 45 | 62 | 98 | 36 | 34 | 42 | 70 | 23 | 30 |
| Operating Profit | -19 | -4 | 8 | 19 | -19 | -11 | 5 | 10 | -13 | -6 |
| Interest | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -21 | -6 | 5 | 17 | -22 | -13 | 3 | 8 | -15 | -9 |
| Provision for Tax | -6 | -2 | 1 | 5 | -6 | -4 | 1 | 2 | -4 | -3 |
| Profit After Tax | -15 | -4 | 4 | 12 | -16 | -10 | 2 | 5 | -11 | -7 |
| Adjustments | -0 | 0 | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 0 |
| Profit After Adjustments | -15 | -4 | 4 | 12 | -16 | -10 | 2 | 5 | -11 | -7 |
| Adjusted Earnings Per Share | -32.9 | -9.4 | 9.3 | 26.3 | -34 | -20.6 | 5 | 11.7 | -23.7 | -14 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 185 | 188 | 210 | 189 | 191 | 202 | 191 | 180 | 224 | 246 | 201 | 158 |
| Other Income | 0 | 0 | 0 | 1 | 1 | 3 | 1 | 1 | 4 | 6 | 3 | 4 |
| Total Income | 185 | 189 | 210 | 190 | 192 | 205 | 192 | 181 | 227 | 251 | 203 | 162 |
| Total Expenditure | 163 | 162 | 178 | 166 | 165 | 178 | 174 | 184 | 204 | 232 | 209 | 165 |
| Operating Profit | 22 | 27 | 33 | 24 | 27 | 27 | 18 | -4 | 24 | 19 | -6 | -4 |
| Interest | 8 | 10 | 10 | 11 | 8 | 8 | 10 | 9 | 6 | 6 | 7 | 8 |
| Depreciation | 3 | 3 | 5 | 4 | 3 | 3 | 2 | 4 | 4 | 3 | 2 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 14 | 17 | 9 | 16 | 17 | 6 | -16 | 10 | 10 | -15 | -13 |
| Provision for Tax | 2 | 3 | 5 | 1 | 4 | 5 | 1 | -6 | 3 | 3 | -4 | -4 |
| Profit After Tax | 9 | 12 | 12 | 8 | 12 | 12 | 5 | -11 | 7 | 8 | -11 | -11 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 9 | 12 | 12 | 8 | 12 | 12 | 5 | -11 | 7 | 8 | -11 | -11 |
| Adjusted Earnings Per Share | 0 | 32.9 | 33.9 | 22.2 | 33.8 | 33.3 | 13.8 | -25.9 | 15.5 | 16.7 | -23.3 | -21 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -18% | 4% | -0% | 1% |
| Operating Profit CAGR | -132% | 0% | NAN% | NAN% |
| PAT CAGR | -238% | 0% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -11% | -20% | -12% | 2% |
| ROE Average | -8% | 1% | -0% | 13% |
| ROCE Average | -5% | 5% | 4% | 15% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 36 | 47 | 58 | 65 | 76 | 86 | 89 | 111 | 135 | 142 | 131 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 23 | 15 | 20 | 25 | 8 | 3 | 15 | 11 | 7 | 14 | 11 |
| Other Non-Current Liabilities | -2 | 1 | 1 | 3 | -8 | -8 | -9 | -12 | -13 | -13 | -18 |
| Total Current Liabilities | 191 | 162 | 167 | 167 | 186 | 232 | 157 | 132 | 188 | 213 | 214 |
| Total Liabilities | 249 | 224 | 246 | 259 | 262 | 313 | 254 | 242 | 317 | 356 | 337 |
| Fixed Assets | 37 | 34 | 30 | 27 | 38 | 36 | 34 | 36 | 33 | 31 | 29 |
| Other Non-Current Assets | 2 | 5 | 9 | 11 | 0 | 1 | 0 | 0 | 1 | 1 | 11 |
| Total Current Assets | 210 | 185 | 206 | 221 | 224 | 276 | 219 | 206 | 282 | 325 | 298 |
| Total Assets | 249 | 224 | 246 | 259 | 262 | 313 | 254 | 242 | 317 | 356 | 337 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 2 | 13 | 3 | 4 | 5 | 5 | 5 | 32 | 27 | 31 |
| Cash Flow from Operating Activities | -9 | 35 | -5 | 13 | 34 | -0 | 2 | 25 | 21 | -1 | 13 |
| Cash Flow from Investing Activities | -1 | -0 | -1 | 1 | -2 | -1 | -0 | 0 | -22 | 5 | -40 |
| Cash Flow from Financing Activities | 10 | -25 | -5 | -12 | -31 | 1 | -2 | 1 | -4 | -1 | 1 |
| Net Cash Inflow / Outflow | -0 | 11 | -10 | 1 | 1 | -1 | 0 | 27 | -5 | 4 | -26 |
| Closing Cash & Cash Equivalent | 2 | 13 | 3 | 4 | 5 | 5 | 5 | 32 | 27 | 31 | 5 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 32.9 | 33.9 | 22.25 | 33.81 | 33.26 | 13.81 | -25.9 | 15.46 | 16.67 | -23.29 |
| CEPS(Rs) | 33.35 | 40.62 | 47.64 | 33.37 | 40.93 | 40.9 | 20.72 | -16.89 | 23.07 | 24.09 | -17.99 |
| DPS(Rs) | 0 | 2.5 | 3 | 3 | 4 | 4 | 1.5 | 0 | 1.5 | 1.5 | 0 |
| Book NAV/Share(Rs) | 0 | 130.33 | 160.63 | 179.26 | 211.3 | 239.67 | 248.27 | 252.71 | 291.92 | 306.32 | 281.74 |
| Core EBITDA Margin(%) | 11.57 | 14.27 | 15.39 | 12.04 | 13.44 | 12.22 | 8.78 | -2.41 | 9.03 | 5.55 | -4.17 |
| EBIT Margin(%) | 10.09 | 13.01 | 13.17 | 10.67 | 12.73 | 12.17 | 7.92 | -4.19 | 7.36 | 6.43 | -4.11 |
| Pre Tax Margin(%) | 5.73 | 7.63 | 8.19 | 4.81 | 8.49 | 8.17 | 2.92 | -9.08 | 4.48 | 4.17 | -7.6 |
| PAT Margin (%) | 4.87 | 6.29 | 5.82 | 4.25 | 6.4 | 5.92 | 2.61 | -5.98 | 3.2 | 3.14 | -5.37 |
| Cash Profit Margin (%) | 6.51 | 7.77 | 8.18 | 6.37 | 7.74 | 7.28 | 3.92 | -3.9 | 4.78 | 4.54 | -4.15 |
| ROA(%) | 7.17 | 5.01 | 5.2 | 3.18 | 4.67 | 4.17 | 1.76 | -4.34 | 2.56 | 2.3 | -3.12 |
| ROE(%) | 47.12 | 28.53 | 23.3 | 13.09 | 17.31 | 14.75 | 5.66 | -11.07 | 5.97 | 5.57 | -7.92 |
| ROCE(%) | 35.51 | 24.34 | 25.8 | 16.88 | 20.67 | 20.15 | 10.89 | -5.15 | 10.73 | 9.54 | -4.81 |
| Receivable days | 101.61 | 109.2 | 127.36 | 161.09 | 165.21 | 179.63 | 173.42 | 139.62 | 115.44 | 133.93 | 157.52 |
| Inventory Days | 228.5 | 202.64 | 165.47 | 187.87 | 201.31 | 222.49 | 254.11 | 234.32 | 183.04 | 193.55 | 248.41 |
| Payable days | 336.98 | 310.63 | 243.22 | 286.91 | 345.35 | 392.44 | 382.34 | 234.18 | 247.41 | 319.5 | 362.88 |
| PER(x) | 0 | 11.76 | 13.51 | 17.13 | 17.44 | 33.33 | 58.5 | 0 | 34.75 | 36.37 | 0 |
| Price/Book(x) | 0 | 2.97 | 2.85 | 2.13 | 2.79 | 4.63 | 3.25 | 1.34 | 1.84 | 1.98 | 1.34 |
| Dividend Yield(%) | 0 | 0.65 | 0.66 | 0.79 | 0.68 | 0.36 | 0.19 | 0 | 0.28 | 0.25 | 0 |
| EV/Net Sales(x) | 0.37 | 0.94 | 1.05 | 1.01 | 1.27 | 2.18 | 1.79 | 0.81 | 1.1 | 1.14 | 1.05 |
| EV/Core EBITDA(x) | 3.14 | 6.52 | 6.75 | 7.93 | 9.05 | 16.11 | 19.39 | -38.47 | 10.3 | 14.58 | -36.31 |
| Net Sales Growth(%) | 0 | 2.01 | 11.34 | -10.03 | 0.94 | 6.19 | -5.76 | -5.61 | 24.34 | 9.86 | -18.27 |
| EBIT Growth(%) | 9706.94 | 31.52 | 12.73 | -27.13 | 20.41 | 1.56 | -38.65 | -149.92 | 318.25 | -3.92 | -152.21 |
| PAT Growth(%) | 6748.59 | 31.87 | 3.04 | -34.38 | 51.99 | -1.64 | -58.49 | -316.24 | 166.65 | 7.83 | -239.67 |
| EPS Growth(%) | 0 | 0 | 3.04 | -34.38 | 51.99 | -1.64 | -58.49 | -287.61 | 159.7 | 7.83 | -239.67 |
| Debt/Equity(x) | 1.85 | 1.1 | 1 | 0.9 | 0.47 | 0.54 | 0.62 | 0.35 | 0.17 | 0.22 | 0.31 |
| Current Ratio(x) | 1.1 | 1.14 | 1.24 | 1.32 | 1.21 | 1.19 | 1.39 | 1.57 | 1.51 | 1.52 | 1.39 |
| Quick Ratio(x) | 0.49 | 0.56 | 0.66 | 0.74 | 0.6 | 0.61 | 0.56 | 0.81 | 0.84 | 0.88 | 0.75 |
| Interest Cover(x) | 2.31 | 2.42 | 2.64 | 1.82 | 3 | 3.04 | 1.58 | -0.86 | 2.55 | 2.84 | -1.18 |
| Total Debt/Mcap(x) | 0 | 0.37 | 0.35 | 0.42 | 0.17 | 0.12 | 0.19 | 0.26 | 0.09 | 0.11 | 0.23 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.11 | 73.11 | 73.11 | 73.11 | 73.11 | 73.11 | 73.11 | 73.11 | 73.11 | 73.11 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 | 26.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
